click

Active Clinical Trials

Carotid Artery Disease

CREST-2; McLaren; Intense Medical Management (IMM) alone vs. Carotid Stent + IMM vs. Carotid Endarterectomy + IMM (open to enrollment)
www.clinicaltrials.gov/CREST-2


ROADSTER 2; McLaren; Transcarotid Stenting with Transcarotid Neuroprotection (open to enrollment)
www.clinicaltrials.gov/ct2/show/NCT02536378


 

Aortic Aneurysmal Disease

ANCHOR; McLaren, Hurley, Genesys: Aptus AAA aortic securement system (open to enrollment) www.clinicaltrials.gov/Anchor


Anaconda; McLaren; Infrarenal (<60) degree angled neck abdominal aortic stent graft (in-follow-up) www.clinicaltrials.gov/Anaconda


The GREAT Registry; McLaren; Endovascular Treatment of Abdominal Aortic Aneurysms, Outcomes Registry (open to enrollment) www.clinicaltrials.gov/GREAT-Registry

Peripheral Arterial Disease

MIMICS-2;  Michigan Vascular Access Center; Superficial Femoral Artery Stent (open to enrollment) www.clinicaltrials.gov/MIMICS-2


BEST-CLI: McLaren, Endovascular vs Surgical Repair of PAD in patients with Critical Limb Ischemia (open to enrollment) www.clinicaltrials.gov/ct2/show/NCT02060630


Humacyte (for PAD); McLaren, Human Acellular Vessel (HAV) for treatment of PAD (coming soon) www.clinicaltrials.gov/ct2/show/NCT02887859

Past Research Trials

Carotid Stenting - 21


Carotid Plaque Evaluation - 1


Carotid Stent Surveillance - 2


Abdominal Aortic Aneurysm Endograft - 6


Aortic Graft Securement - 1


Abdominal Aortic Aneurysm Sensor - 1


Peripheral Stenting - 3


Peripheral Stent/Drug Eluting - 2


Renal Stenting - 1


Renal Lesions Outcome - 1


Peripheral Arterial Disease (PAD) Drug Trials - 7


Deep Venous Thrombosis (DVT) Trials - 2


Inferior Vena Cava (IVC) Filter - 1


Surgical Hemostasis - 3


Wound Covering - 1


Hemodialysis Access Stent - 1


Hemodialysis Access Wrap - 3


Arterio-Venous Fistula (AVF) Drug Study - 1


Retrospective Data Studies - 5

Renal/Hemodialysis Studies

Lutonix AV Study; Michigan Vascular Access Center; Drug coated Balloon PTA vs. Standard Balloon PTA for Dysfunctional AV Fistulae (in follow-up)


Humacyte (for Dialysis); Michigan Vascular Access Center; Human Acellular Vessel (HAV) vs. ePTFE Grafts for Dialysis Conduits (open to enrollment) 

Venous Disease

VIRTUS; Michigan Vascular Access Center; Venous Stenting of Iliofemoral Venous Segment (open to enrollment) www.clinicaltrials.gov/ct2/show/NCT02112877